12/20
04:30 pm
teva
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
Neutral
Report
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
12/20
05:00 am
teva
My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]
Medium
Report
My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]
12/18
11:06 pm
teva
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
12/18
10:19 am
teva
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.
12/18
08:48 am
teva
Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength? [Yahoo! Finance]
12/18
08:25 am
teva
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
12/17
04:40 pm
teva
Teva and Sanofi jump on experimental bowel disease drug success [Yahoo! Finance]
Low
Report
Teva and Sanofi jump on experimental bowel disease drug success [Yahoo! Finance]
12/17
07:30 am
teva
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
High
Report
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
12/11
08:08 am
teva
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients [Yahoo! Finance]
Low
Report
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients [Yahoo! Finance]
12/11
08:00 am
teva
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
Low
Report
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
12/10
11:51 am
teva
Medincell Publishes Its Consolidated Half-year Financial Results [Yahoo! Finance]
Low
Report
Medincell Publishes Its Consolidated Half-year Financial Results [Yahoo! Finance]
12/9
02:20 pm
teva
EUROAPI moves into a new chapter with new Governance and Leadership [Yahoo! Finance]
Low
Report
EUROAPI moves into a new chapter with new Governance and Leadership [Yahoo! Finance]
12/9
01:13 pm
teva
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement [Yahoo! Finance]
Low
Report
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement [Yahoo! Finance]
12/6
08:02 am
teva
Can Teva Return To All-Time Highs? [Seeking Alpha]
Low
Report
Can Teva Return To All-Time Highs? [Seeking Alpha]
12/5
06:00 pm
teva
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
Low
Report
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
12/4
02:06 am
teva
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial [Yahoo! Finance]
Low
Report
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial [Yahoo! Finance]
12/4
02:00 am
teva
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
Low
Report
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
11/25
06:00 pm
teva
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
Low
Report
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
11/25
10:04 am
teva
Intranasal Drug and Vaccine Delivery Market Research Report 2025-2030: Multi-dose Intranasal Systems Excel, Offering Convenience and Reduced Need for Refills [Yahoo! Finance]
Low
Report
Intranasal Drug and Vaccine Delivery Market Research Report 2025-2030: Multi-dose Intranasal Systems Excel, Offering Convenience and Reduced Need for Refills [Yahoo! Finance]
11/18
02:18 pm
teva
Community Routes: Access to Mental Health Care [Yahoo! Finance]
Low
Report
Community Routes: Access to Mental Health Care [Yahoo! Finance]
11/18
09:53 am
teva
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug [Yahoo! Finance Canada]
Low
Report
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug [Yahoo! Finance Canada]
11/14
11:43 am
teva
Global Plant-Based API Market Set to Reach USD 52,085.9 Million by 2034, Expected to Grow at a CAGR of 5.6% | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Global Plant-Based API Market Set to Reach USD 52,085.9 Million by 2034, Expected to Grow at a CAGR of 5.6% | Future Market Insights, Inc. [Yahoo! Finance]
11/8
04:30 pm
teva
Teva to Present at the Jefferies London Healthcare Conference
Low
Report
Teva to Present at the Jefferies London Healthcare Conference
11/8
10:59 am
teva
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? [Yahoo! Finance]
Low
Report
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? [Yahoo! Finance]
11/7
02:19 am
teva
Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ... [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ... [Yahoo! Finance]